A reversible syndrome of headache, altered mental status, seizures and cerebral visual abnormalities with neuroradiological studies suggesting predominantly posterior white matter abnormalities has been described. This syndrome has been referred to as posterior reversible encephalopathic syndrome (PRES). PRES has been associated with hypertensive encephalopathy, eclampsia and treatment with immunosuppressive or cytotoxic agents. Rare case reports describe association with hypercalcemia. We present a patient with AIDS, Mycobacterium avium intracellulare related hypercalcemia with posterior reversible encephalopathic syndrome.
Background: Accurate quantitation of plasma Human immunodeficiency virus-1 (HIV) RNA levels is required for clinical management of HIV-1-infected patients. Several assays are used to quantify HIV RNA, and prior to implementing a change in viral load method, continuity in reported values is addressed by the laboratory and communicated to clinicians. Methods: We initially compared COBAS ® AmpliPrep-COBAS ® TaqMan 48 (TaqMan) v.1.0 (Roche) to prior methodology, branched-chain DNA (bDNA) v.3.0 (Siemens) to determine if establishment of new patient baselines were necessary. Study data from 81 specimens run by both assays were compared using nonparametric tests, e.g., Wilcoxon signed-rank, Spearman. Subsets for comparison included only those that fell into overlapping ranges for both assays. Results: The methods correlated (Spearman correlation, rs = 0.91), but TaqMan values were significantly higher than those of bDNA (p<0.0001). Based upon this, new baselines (n=768) collected over 6-months were determined by running bDNA on all specimens that could be quantitated by TaqMan (n=308). Of those with sufficient quantity to establish new baselines with the TaqMan, 308 and 272 were quantifiable by TaqMan and bDNA, respectively. Parallel data within overlapping ranges (n=262) were again highly correlated (rs =0.89), but still were statistically different (p =0.0044). Additional analyses for regression and pair differences by range were run on combined (study and parallel) data. Conclusion: Our data demonstrate non-equivalence in HIV-1 RNA values of TaqMan v.1.0 as compared to bDNA v.3.0, and that new baselines for HIV viral load RNA HIV-1 should be re-established. New baselines for those patients missed by parallel testing can be calculated using regression analysis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.